The Food and Drug Administration is expected next week to grant full approval of the COVID-19 vaccine from Pfizer Inc. and partner BioNTech SE, according to people familiar with the planning, an action that could spur more vaccination requirements by employers and encourage more people who are hesitant to get vaccinated.

from MarketWatch.com - Top Stories https://ift.tt/37Xwa8S
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/37Xwa8S
via IFTTT
Kommentare
Kommentar veröffentlichen